Therefore, dual blockade of TIGIT and PD‐1 is hypothesized to more effectively restore CD226‐mediated co‐stimulation, potentially reversing T cell exhaustion and enhancing anti‐tumor immunity. Here, PDCD1 is linked to neoplasm.